MedPath

Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin and 5-fluorouracil against epirubicin, cisplatin and 5-fluorouracil

Completed
Conditions
Gastric cancer
Cancer
Registration Number
ISRCTN83369741
Lead Sponsor
Tehran University of Medical Sciences (Iran)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
86
Inclusion Criteria

Patients with histologically confirmed advanced gastric cancer

Exclusion Criteria

Patients with local or local- regional gastric cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Quality of life and survival
© Copyright 2025. All Rights Reserved by MedPath